[Tree] Intellectual property and innovation for inventors
Version 0.25 (2024-08-28 17:44:15.241000)
updates: Added details on patent trolls and their effects
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.24 (2024-08-14 18:14:40.393000)
updates: The article 'Time to fight back against patent assaults' discusses the need to fight back against patent trolls who are exploiting the patent system and hindering innovation. The author argues that Congress should pass legislation to address the issue and highlights the importance of protecting intellectual property rights. The article also mentions the negative impact of patent trolls on small businesses and calls for a balanced approach to patent reform. The role of the courts in addressing patent disputes is mentioned, and the author emphasizes the need for a fair and efficient patent system [54b6e62b].
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.23 (2024-08-10 16:59:21.276000)
updates: Inclusion of information about proposed government guidance on intellectual property ownership in the US
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.22 (2024-07-30 17:08:56.849000)
updates: Integrates information about the impact of third-party litigation funding on intellectual property rights in the US
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.21 (2024-07-22 11:59:45.199000)
updates: Integration of concerns about foreign interference in patent litigation
- ➔
- ➔
- ➔
- ➔
Version 0.2 (2024-07-17 01:54:11.822000)
updates: Discussion on the risks of losing ground in R&D and the need for increased federal investment and research reform
- ➔
- ➔
- ➔
Version 0.19 (2024-06-18 20:53:46.753000)
updates: The US patent system and the need for a pro-patent innovation policy
- ➔
- ➔
Version 0.18 (2024-06-10 12:56:52.471000)
updates: Discussion on the importance of protecting American innovation
- ➔
Version 0.17 (2024-06-05 22:52:56.789000)
updates: The article highlights the opposition to the Biden administration's proposal from the National Association of Manufacturers (NAM) and the U.S. Chamber of Commerce. It also mentions the letter submitted to the administration by the Health Policy Consensus Group opposing the proposal. Additionally, the article introduces the perspective of legal experts who argue that the proposal would undermine the historic innovation pipeline created by the Bayh-Dole Act. The article also mentions the challenge from the U.S. Chamber of Commerce regarding FOIA requests on 'march-in rights' and the criticism faced by the Biden administration for its proposal to reinterpret the Bayh-Dole Act. Finally, the article discusses the importance of patent modernization in Minnesota's innovation economy and calls for the passage of two bills, PERA and PREVAIL, to protect patent rights and strengthen the U.S. patent system.
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.16 (2024-05-30 20:55:24.438000)
updates: The new information highlights the opposition to the Biden administration's proposal from the National Association of Manufacturers (NAM) and the U.S. Chamber of Commerce. It also provides additional context on the Bayh-Dole Act and the potential impact of the proposal on American innovation. The criticism from the U.S. Chamber of Commerce regarding the stonewalling of FOIA requests and the need for transparency is also included. The article from the Daily Caller emphasizes the potential destruction of jobs and innovation if the proposal is finalized. The concerns raised by the National Association of Manufacturers and the Association of American Universities are mentioned as well.
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.15 (2024-04-19 19:22:42.132000)
updates: Integration of the U.S. Chamber of Commerce's opposition and call for transparency
- ➔
- ➔
- ➔
- ➔
Version 0.14 (2024-03-20 13:17:35.526000)
updates: Opposition from the U.S. Chamber of Commerce
- ➔
- ➔
- ➔
Version 0.13 (2024-03-11 08:21:40.283000)
updates: The addition of concerns about the impact on innovation from the Biden administration's proposal to reduce drug prices
- ➔
- ➔
Version 0.12 (2024-03-01 10:16:51.645000)
updates: The Biden administration's proposal to reshape America's innovation economy by imposing price controls and seizing control of patents is facing opposition from the National Association of Manufacturers (NAM). The NAM argues that this proposal would undermine the American innovation economy and have sweeping ramifications for manufacturers' intellectual property rights. They emphasize that such a move would particularly impact start-ups and small businesses. The NAM is urging the administration to withdraw the proposal and provide certainty to manufacturers and stakeholders in the innovation economy. Additionally, the NAM points out that the march-in provision of the Bayh-Dole Act, which allows the government to intervene during times of crisis to ensure consumer access to certain products, has never been used since its enactment in 1980. To further oppose the proposal, the NAM has launched a seven-figure ad campaign. In 1980, Senators Bob Dole and Birch Bayh passed the Bayh-Dole bill, which allowed private entities to bring new products to market using federally funded research. However, the Biden administration wants to allow competitors to take over patents if they deem the price of the product to be unreasonable, which could damage innovation and medical progress. A letter was submitted to the administration opposing this proposal, stating that it would be an assault on intellectual property rights and weaken the economy. The Health Policy Consensus Group participated in signing the letter. [73a4c4fd]
- ➔
- ➔
Version 0.11 (2024-02-09 14:16:03.604000)
updates: Opposition to Biden's 'march-in' rights proposal
- ➔
- ➔
Version 0.1 (2024-02-07 15:11:54.831000)
updates: Opposition from the National Association of Manufacturers (NAM) to the Biden administration's proposal
- ➔
Version 0.09 (2024-01-28 10:53:38.418000)
updates: Commentary by Jon Soderstrom on the impact of the Bayh-Dole Act and the proposed changes
- ➔
- ➔
- ➔
Version 0.08 (2024-01-25 10:59:18.719000)
updates: The Biden administration's framework for lowering prescription drug prices through march-in rights
- ➔
- ➔
Version 0.07 (2024-01-24 17:01:32.033000)
updates: Opposition to Biden administration's march-in rights proposal
- ➔
- ➔
Version 0.06 (2024-01-21 09:05:55.593000)
updates: Includes insights from a UP lawyer on the importance of patenting inventions
- ➔
Version 0.05 (2024-01-14 21:16:57.877000)
updates: Includes an opinion piece on Biden's proposal to seize patents
- ➔
Version 0.04 (2024-01-08 14:28:14.059000)
updates: Biden administration's plan to seize patent rights raises concerns about small business and innovation
- ➔
- ➔
- ➔
- ➔
Version 0.03 (2024-01-08 13:19:03.141000)
updates: Includes information about the Biden administration's plan to lower drug prices and its potential impact on small businesses and innovation
- ➔
- ➔
- ➔
Version 0.02 (2024-01-08 08:23:22.292000)
updates: Inclusion of Biden's plan to lower drug prices and its potential impact on innovation
- ➔
- ➔
Version 0.01 (2023-12-20 02:59:51.586000)
updates: Added information about the Bayh-Dole Act and its impact on healthcare and innovation
- ➔